79 related articles for article (PubMed ID: 8085845)
1. [Late phase II clinical study of KW-2307 in previously untreated patients with non-small cell lung cancer. KW-2307 Study Group (Lung Cancer Group)].
Furuse K; Kinuwaki E; Motomiya M; Nishiwaki H; Hasegawa K; Kobayashi K; Kurita Y; Ohta K; Fukuoka M; Nakajima S
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1941-7. PubMed ID: 8085845
[TBL] [Abstract][Full Text] [Related]
2. [Early phase II clinical study of KW-2307 in patients with lung cancer. Lung Cancer Section in KW-2307 Study Group].
Furuse K; Ohta M; Fukuoka M; Kurita Y; Kobayashi K; Hasegawa K; Kimura I; Fujii M; Yoshida S; Kitamura S
Gan To Kagaku Ryoho; 1994 May; 21(6):785-93. PubMed ID: 8185336
[TBL] [Abstract][Full Text] [Related]
3. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
[TBL] [Abstract][Full Text] [Related]
4. [Phase I clinical study on new vinca alkaloid derivative, KW-2307 (vinorelbine). KW-2307 Study Group].
Niitani H; Furuse K; Fukuoka M; Hasegawa K; Taguchi T
Gan To Kagaku Ryoho; 1994 Feb; 21(2):177-87. PubMed ID: 8311488
[TBL] [Abstract][Full Text] [Related]
5. [Early phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section].
Tominaga T; Nomura Y; Adachi I; Takashima S; Kimura M; Koyama H; Toge T; Tamura K; Hayasaka H; Kunii Y
Gan To Kagaku Ryoho; 1994 May; 21(6):801-8. PubMed ID: 8185337
[TBL] [Abstract][Full Text] [Related]
6. [Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section)].
Tominaga T; Nomura Y; Adachi I; Aoyama H; Nagao K; Mitsuyama S; Nakamura Y; Ogita M; Sano M; Takashima S
Gan To Kagaku Ryoho; 1994 May; 21(6):809-16. PubMed ID: 8185338
[TBL] [Abstract][Full Text] [Related]
7. [Phase-I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients].
Yamamoto M; Ariyoshi Y; Hasegawa K; Kobayashi K; Fukuoka M; Kurita Y; Sakuma A; Furuse K; Niitani H
Gan To Kagaku Ryoho; 1994 Jun; 21(7):993-9. PubMed ID: 8002639
[TBL] [Abstract][Full Text] [Related]
8. [Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].
Tominaga T; Nomura Y; Horikoshi N; Takashima S; Kimura M; Koyama H; Kikkawa N; Toge T; Mitsuyama S; Morimoto T; Enomoto K; Wada T; Kimishima I; Niitani H;
Gan To Kagaku Ryoho; 2005 Jul; 32(7):983-90. PubMed ID: 16044960
[TBL] [Abstract][Full Text] [Related]
9. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).
Depierre A; Lemarie E; Dabouis G; Garnier G; Jacoulet P; Dalphin JC
Semin Oncol; 1989 Apr; 16(2 Suppl 4):26-9. PubMed ID: 2540532
[No Abstract] [Full Text] [Related]
11. [Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)].
Fukuoka M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1825-32. PubMed ID: 8937493
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerance of Navelbine in phase I-II clinical studies.
Besenval M; Delgado M; Demarez JP; Krikorian A
Semin Oncol; 1989 Apr; 16(2 Suppl 4):37-40. PubMed ID: 2540533
[No Abstract] [Full Text] [Related]
13. [Analysis of adverse events of amrubicin hydrochloride for pretreated lung cancer patients].
Takase M; Maruoka H; Maeda R; Shibata K
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1789-92. PubMed ID: 18030011
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of platinum combination chemotherapy re-challenge for relapsed patients with non-small-cell lung cancer after postoperative adjuvant chemotherapy of cisplatin plus vinorelbine.
Imai H; Shukuya T; Yoshino R; Muraki K; Mori K; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Tomizawa Y; Takahashi T; Takahashi K; Saito R; Yamamoto N
Chemotherapy; 2013; 59(4):307-13. PubMed ID: 24480845
[TBL] [Abstract][Full Text] [Related]
15. Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report.
Vokes EE; Rosenberg R; Jahanzeb M; Craig J; Gralla R; Belani C; Jones S; Bigley J; Hohneker J
Semin Oncol; 1994 Oct; 21(5 Suppl 10):35-8; discussion 38-41. PubMed ID: 7973767
[TBL] [Abstract][Full Text] [Related]
16. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer.
Sugiura T; Ariyoshi Y; Negoro S; Nakamura S; Ikegami H; Takada M; Yana T; Fukuoka M
Invest New Drugs; 2005 Aug; 23(4):331-7. PubMed ID: 16012792
[TBL] [Abstract][Full Text] [Related]
18. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
Vokes EE; Rosenberg RK; Jahanzeb M; Craig JB; Gralla RJ; Belani CP; Jones SE; Bigley JW; Hohneker JA
J Clin Oncol; 1995 Mar; 13(3):637-44. PubMed ID: 7533824
[TBL] [Abstract][Full Text] [Related]
19. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
Anticancer Res; 1994; 14(3B):1413-5. PubMed ID: 8067715
[TBL] [Abstract][Full Text] [Related]
20. Vinorelbine monochemotherapy in non-small-cell lung cancer: experience in patients with low performance status.
Masotti A; Zannini G; Poggi R; Morandini GC
Monaldi Arch Chest Dis; 1994 Jun; 49(3):197-200. PubMed ID: 8087113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]